Market Watch List: Hewlett-Packard Company (NYSE:HPQ), Halcon Resources Corporation (NYSE:HK), Catamaran Corporation (NASDAQ:CTRX), Kite Pharma, Inc. (NASDAQ:KITE), AECOM Technology Corporation (NYSE:ACM)

Hewlett-Packard Company (NYSE:HPQ) confirms it sold off Palm’s trademarks. After buying the brand for $1.2 billion in 2010, HP has now sold-off the trademarks associated with Palm, a spokeswoman for the company told CNBC. Hewlett-Packard Company (NYSE:HPQ) belongs to Technology sector. Its net profit margin is 4.50% and weekly performance is -0.74%. On last trading day company shares ended up $40.24. Hewlett-Packard Company (NYSE:HPQ) distance from 50-day simple moving average (SMA50) is 7.19%.

Shares of Halcon Resources Corp (NYSE:HK) were the target of a large decline in short interest in November. As of November 28th, there was short interest totalling 61,607,682 shares, a decline of 7.8% from the November 14th total of 66,822,771 shares, reports. Halcon Resources Corporation (NYSE:HK) shares moved up 5.06% in last trading session and ended the day at $1.87. HK Gross Margin is 78.00% and its return on assets is -6.70%. Halcon Resources Corporation (NYSE:HK) quarterly performance is -51.30%.

Citigroup Inc. reiterated their neutral rating on shares of Catamaran Corp (NASDAQ:CTRX) in a research note released on Friday morning. They currently have a $51.00 target price on the stock, up from their previous target price of $48.00. On 02 January, Catamaran Corporation (NASDAQ:CTRX) shares moved up 0.89% and was closed at $52.21. CTRX EPS growth in last 5 year was 51.30%. Catamaran Corporation (NASDAQ:CTRX) year to date (YTD) performance is 0.89%.

On Dec 30, Kite Pharma, Inc. (NASDAQ:KITE) announced that the underwriters of its previously announced follow-on public offering of 3,485,000 shares of common stock have exercised in full their option to purchase an additional 522,750 shares of common stock at the public offering price of $54 per share, less customary underwriting discounts and commissions. Kite Pharma, Inc. (NASDAQ:KITE) ended the last trading day at $60.61. Company weekly volatility is calculated as 5.72% and price to cash ratio as 12.98. Kite Pharma, Inc. (NASDAQ:KITE) showed a weekly performance of 16.65%.

AECOM Technology Corp (NYSE:ACM) Director Clarence T. Schmitz purchased 3,000 shares of the stock on the open market in a transaction that occurred on Wednesday, December 10th. The stock was purchased at an average price of $29.61 per share, with a total value of $88,830.00. AECOM Technology Corporation (NYSE:ACM) shares fell -0.07% in last trading session and ended the day at $30.35. ACM Gross Margin is 4.80% and its return on assets is 3.90%. AECOM Technology Corporation (NYSE:ACM) quarterly performance is -7.38%.